SC Agrees to Examine Plea for Code to Curb Unethical Marketing Practices of Pharma Companies
Advertisement
The Supreme Court on Friday agreed to examine a plea seeking a direction to Centre for formulating a Uniform Code of Pharmaceutical Marketing Practices (UCPMP) to curb unethical practices of Pharma companies and ensure an effective monitoring mechanism, transparency, accountability as well as consequences of violations.
A bench of Justices DY Chandrachud and Surya Kant issued notice to the Centre seeking its response in six weeks saying it wants to know what the government has to say on this issue.
For more information check out the full story on the link below:
Unethical Marketing Practices Of Pharma Companies: SC to examine UCPMP code implementation
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.